Systematic evaluation of immune regulation and modulation

David F. Stroncek, Lisa H. Butterfield, Michael A. Cannarile, Madhav V. Dhodapkar, Tim F. Greten, Jean-Charles B. Grivel, David R. Kaufman, Heidi H. Kong, Firouzeh Korangy, Peter P. Lee, Francesco Marincola, Sergio Rutella, Janet C. Siebert, Giorgio Trinchieri, Barbara Seliger

Research output: Contribution to journalReview article

12 Citations (Scopus)

Abstract

Cancer immunotherapies are showing promising clinical results in a variety of malignancies. Monitoring the immune as well as the tumor response following these therapies has led to significant advancements in the field. Moreover, the identification and assessment of both predictive and prognostic biomarkers has become a key component to advancing these therapies. Thus, it is critical to develop systematic approaches to monitor the immune response and to interpret the data obtained from these assays. In order to address these issues and make recommendations to the field, the Society for Immunotherapy of Cancer reconvened the Immune Biomarkers Task Force. As a part of this Task Force, Working Group 3 (WG3) consisting of multidisciplinary experts from industry, academia, and government focused on the systematic assessment of immune regulation and modulation. In this review, the tumor microenvironment, microbiome, bone marrow, and adoptively transferred T cells will be used as examples to discuss the type and timing of sample collection. In addition, potential types of measurements, assays, and analyses will be discussed for each sample. Specifically, these recommendations will focus on the unique collection and assay requirements for the analysis of various samples as well as the high-throughput assays to evaluate potential biomarkers.

Original languageEnglish
Article number21
JournalJournal for ImmunoTherapy of Cancer
Volume5
Issue number1
DOIs
Publication statusPublished - 21 Mar 2017

Fingerprint

Biomarkers
Advisory Committees
Immunotherapy
Neoplasms
Immunologic Monitoring
Tumor Microenvironment
Microbiota
Industry
Bone Marrow
T-Lymphocytes
Therapeutics

Keywords

  • High-throughput
  • Immune biomarkers
  • Immune regulation
  • Systematic monitoring

ASJC Scopus subject areas

  • Oncology
  • Immunology and Allergy
  • Cancer Research
  • Molecular Medicine
  • Pharmacology
  • Immunology

Cite this

Stroncek, D. F., Butterfield, L. H., Cannarile, M. A., Dhodapkar, M. V., Greten, T. F., Grivel, J-C. B., ... Seliger, B. (2017). Systematic evaluation of immune regulation and modulation. Journal for ImmunoTherapy of Cancer, 5(1), [21]. https://doi.org/10.1186/s40425-017-0223-8

Systematic evaluation of immune regulation and modulation. / Stroncek, David F.; Butterfield, Lisa H.; Cannarile, Michael A.; Dhodapkar, Madhav V.; Greten, Tim F.; Grivel, Jean-Charles B.; Kaufman, David R.; Kong, Heidi H.; Korangy, Firouzeh; Lee, Peter P.; Marincola, Francesco; Rutella, Sergio; Siebert, Janet C.; Trinchieri, Giorgio; Seliger, Barbara.

In: Journal for ImmunoTherapy of Cancer, Vol. 5, No. 1, 21, 21.03.2017.

Research output: Contribution to journalReview article

Stroncek, DF, Butterfield, LH, Cannarile, MA, Dhodapkar, MV, Greten, TF, Grivel, J-CB, Kaufman, DR, Kong, HH, Korangy, F, Lee, PP, Marincola, F, Rutella, S, Siebert, JC, Trinchieri, G & Seliger, B 2017, 'Systematic evaluation of immune regulation and modulation', Journal for ImmunoTherapy of Cancer, vol. 5, no. 1, 21. https://doi.org/10.1186/s40425-017-0223-8
Stroncek DF, Butterfield LH, Cannarile MA, Dhodapkar MV, Greten TF, Grivel J-CB et al. Systematic evaluation of immune regulation and modulation. Journal for ImmunoTherapy of Cancer. 2017 Mar 21;5(1). 21. https://doi.org/10.1186/s40425-017-0223-8
Stroncek, David F. ; Butterfield, Lisa H. ; Cannarile, Michael A. ; Dhodapkar, Madhav V. ; Greten, Tim F. ; Grivel, Jean-Charles B. ; Kaufman, David R. ; Kong, Heidi H. ; Korangy, Firouzeh ; Lee, Peter P. ; Marincola, Francesco ; Rutella, Sergio ; Siebert, Janet C. ; Trinchieri, Giorgio ; Seliger, Barbara. / Systematic evaluation of immune regulation and modulation. In: Journal for ImmunoTherapy of Cancer. 2017 ; Vol. 5, No. 1.
@article{96782f41942f40fd969f02c1d08d6e9b,
title = "Systematic evaluation of immune regulation and modulation",
abstract = "Cancer immunotherapies are showing promising clinical results in a variety of malignancies. Monitoring the immune as well as the tumor response following these therapies has led to significant advancements in the field. Moreover, the identification and assessment of both predictive and prognostic biomarkers has become a key component to advancing these therapies. Thus, it is critical to develop systematic approaches to monitor the immune response and to interpret the data obtained from these assays. In order to address these issues and make recommendations to the field, the Society for Immunotherapy of Cancer reconvened the Immune Biomarkers Task Force. As a part of this Task Force, Working Group 3 (WG3) consisting of multidisciplinary experts from industry, academia, and government focused on the systematic assessment of immune regulation and modulation. In this review, the tumor microenvironment, microbiome, bone marrow, and adoptively transferred T cells will be used as examples to discuss the type and timing of sample collection. In addition, potential types of measurements, assays, and analyses will be discussed for each sample. Specifically, these recommendations will focus on the unique collection and assay requirements for the analysis of various samples as well as the high-throughput assays to evaluate potential biomarkers.",
keywords = "High-throughput, Immune biomarkers, Immune regulation, Systematic monitoring",
author = "Stroncek, {David F.} and Butterfield, {Lisa H.} and Cannarile, {Michael A.} and Dhodapkar, {Madhav V.} and Greten, {Tim F.} and Grivel, {Jean-Charles B.} and Kaufman, {David R.} and Kong, {Heidi H.} and Firouzeh Korangy and Lee, {Peter P.} and Francesco Marincola and Sergio Rutella and Siebert, {Janet C.} and Giorgio Trinchieri and Barbara Seliger",
year = "2017",
month = "3",
day = "21",
doi = "10.1186/s40425-017-0223-8",
language = "English",
volume = "5",
journal = "Journal for ImmunoTherapy of Cancer",
issn = "2051-1426",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Systematic evaluation of immune regulation and modulation

AU - Stroncek, David F.

AU - Butterfield, Lisa H.

AU - Cannarile, Michael A.

AU - Dhodapkar, Madhav V.

AU - Greten, Tim F.

AU - Grivel, Jean-Charles B.

AU - Kaufman, David R.

AU - Kong, Heidi H.

AU - Korangy, Firouzeh

AU - Lee, Peter P.

AU - Marincola, Francesco

AU - Rutella, Sergio

AU - Siebert, Janet C.

AU - Trinchieri, Giorgio

AU - Seliger, Barbara

PY - 2017/3/21

Y1 - 2017/3/21

N2 - Cancer immunotherapies are showing promising clinical results in a variety of malignancies. Monitoring the immune as well as the tumor response following these therapies has led to significant advancements in the field. Moreover, the identification and assessment of both predictive and prognostic biomarkers has become a key component to advancing these therapies. Thus, it is critical to develop systematic approaches to monitor the immune response and to interpret the data obtained from these assays. In order to address these issues and make recommendations to the field, the Society for Immunotherapy of Cancer reconvened the Immune Biomarkers Task Force. As a part of this Task Force, Working Group 3 (WG3) consisting of multidisciplinary experts from industry, academia, and government focused on the systematic assessment of immune regulation and modulation. In this review, the tumor microenvironment, microbiome, bone marrow, and adoptively transferred T cells will be used as examples to discuss the type and timing of sample collection. In addition, potential types of measurements, assays, and analyses will be discussed for each sample. Specifically, these recommendations will focus on the unique collection and assay requirements for the analysis of various samples as well as the high-throughput assays to evaluate potential biomarkers.

AB - Cancer immunotherapies are showing promising clinical results in a variety of malignancies. Monitoring the immune as well as the tumor response following these therapies has led to significant advancements in the field. Moreover, the identification and assessment of both predictive and prognostic biomarkers has become a key component to advancing these therapies. Thus, it is critical to develop systematic approaches to monitor the immune response and to interpret the data obtained from these assays. In order to address these issues and make recommendations to the field, the Society for Immunotherapy of Cancer reconvened the Immune Biomarkers Task Force. As a part of this Task Force, Working Group 3 (WG3) consisting of multidisciplinary experts from industry, academia, and government focused on the systematic assessment of immune regulation and modulation. In this review, the tumor microenvironment, microbiome, bone marrow, and adoptively transferred T cells will be used as examples to discuss the type and timing of sample collection. In addition, potential types of measurements, assays, and analyses will be discussed for each sample. Specifically, these recommendations will focus on the unique collection and assay requirements for the analysis of various samples as well as the high-throughput assays to evaluate potential biomarkers.

KW - High-throughput

KW - Immune biomarkers

KW - Immune regulation

KW - Systematic monitoring

UR - http://www.scopus.com/inward/record.url?scp=85015623660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015623660&partnerID=8YFLogxK

U2 - 10.1186/s40425-017-0223-8

DO - 10.1186/s40425-017-0223-8

M3 - Review article

C2 - 28331613

AN - SCOPUS:85015623660

VL - 5

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

SN - 2051-1426

IS - 1

M1 - 21

ER -